BostonGene pricing
No list price or self pay rate is published. The company bills insurance first, states that Tumor Portrait is in network with Medicare and that it works with all US insurers, and offers a financial assistance program that covers all tests ordered within 18 months of approval for eligible US residents, plus a discounted fee and payment plan for self pay patients. A balance billing disclosure is published. Biopharma services are contracted separately with no published rates.
How BostonGene pricing works
- Pricing model
- Per test billed to insurance, in network with Medicare, with a financial assistance program and self pay discount; biopharma work contracted separately
BostonGene pricing against its alternatives
Published prices for BostonGene and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- BBostonGeneNo published price
- CCaris Life SciencesNo published price
- 44baseCareNo published price
- GGRAIL$949 per test (list price)
- BbioAffinity TechnologiesNo published price
- VVeracyteNo published price
- MMyOmeNo published price
- AAmbry GeneticsNot published; 9 in 10 patients pay $0
- FFoundation MedicineNo published price
BostonGene pricing, answered
How much does BostonGene cost?
BostonGene does not publish a price. The company bills insurance first, states that Tumor Portrait is in network with Medicare and that it works with all US insurers, and offers a financial assistance program that covers all tests ordered within 18 months of approval for eligible US residents, plus a discounted fee and payment plan for self pay patients. A balance billing disclosure is published.